EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding.

Date Range:

Author:

Topic:

Refine Category Search

Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

New and Revised FDA Import Alerts for April 16

April 17, 2013 by Brian Feito|FDA

On April 16 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

New and Revised FDA Import Alerts for April 15

April 16, 2013 by Brian Feito|FDA

On April 15 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

Other Modified FDA Import Alerts for the Week of April 8-14

April 16, 2013 by Brian Feito|FDA

During the week of April 8-14, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:

FDA Proposes Selenium Standard and Labeling for Infant Formula

April 16, 2013 by Brian Feito|FDA

The Food and Drug Administration is proposing to establish minimum and maximum levels of selenium in infant formula. The proposed rule would also add selenium to the statement of amounts of nutrients for infant formula labeling, to be listed between iodine and sodium. Comments on the proposed rule are due by July 1, except for comments on proposed information collection requirements, which are due by May 16.

FDA Generic Drug Facility Self-Identification for FY 2014 to Run May 1 - June 1

April 16, 2013 by Brian Feito|FDA

The Food and Drug Administration will begin its month-long reporting period for generic drug facility self-identification for fiscal year 2014 on May 1. Between May 1 and June 1, generic drug facilities, certain sites, and organizations identified in a generic drug submission are required to submit, update, or reconfirm identification information to FDA, it said. More information, including generic drug facilities that have to register, is available (here).

New and Revised FDA Import Alerts for April 12-14

April 15, 2013 by Brian Feito|FDA

On April 12-14 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

New and Revised FDA Import Alerts for April 11

April 12, 2013 by Brian Feito|FDA

On April 11 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA Enforcement Report on Recalls & Field Corrections for April 10

April 12, 2013 by Brian Feito|FDA

The Food and Drug Administration issued its weekly Enforcement Report for April 10 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

New and Revised FDA Import Alerts for April 10

April 11, 2013 by Brian Feito|FDA

On April 10 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA Threatens Guatemalan and Costa Rican Produce Farms with Import Refusal for Unsanitary Conditions

April 11, 2013 by Brian Feito|FDA

The Food and Drug Administration threatened to refuse imports from Guatemalan and Costa Rican produce farms and packing houses after finding “objectionable conditions and practices” at each, according to two agency warning letters.